Tiracizine disposition in healthy volunteers with reference to the debrisoquine oxidation phenotype.

Παρόμοια τεκμήρια

• Debrisoquine oxidation phenotype and susceptibility to lung cancer.
  ανά: Boobis, A R, κ.ά.
  Έκδοση: (1990)
• Genetically determined oxidation capacity and the disposition of debrisoquine.
  ανά: Sloan, T P, κ.ά.
  Έκδοση: (1983)
• The pharmacokinetics of ondansetron after intravenous injection in healthy volunteers phenotyped as poor or extensive metabolisers of debrisoquine.
  ανά: Ashforth, E I, κ.ά.
  Έκδοση: (1994)
• Stereoselective disposition of flecainide in relation to the sparteine/debrisoquine metaboliser phenotype.
  ανά: Gross, A S, κ.ά.
  Έκδοση: (1989)
• Disposition of Intravenous Pyrimethamine in Healthy Volunteers
  ανά: Almond, D. S., κ.ά.
  Έκδοση: (2000)